Home > Boards > US Listed > Biotechs > Evelo Biosciences Inc (EVLO)

Anyone Here?

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
beginneer Member Profile
Member Level 
Followed By 13
Posts 1,059
Boards Moderated 1
Alias Born 10/27/16
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2021 4:11:40 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/16/2021 4:14:52 PM
Evelo Biosciences Announces Grant of Inducement Award GlobeNewswire Inc. - 6/16/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2021 4:08:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2021 4:07:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2021 4:04:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2021 4:03:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2021 6:00:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 4:50:17 PM
Evelo Biosciences Announces Inducement Award Plan for Expanding Leadership Team GlobeNewswire Inc. - 6/3/2021 4:01:00 PM
Evelo Biosciences Announces Appointment of Mark Plinio as Chief Commercial Officer GlobeNewswire Inc. - 6/1/2021 7:00:00 AM
Evelo Biosciences to Present at Upcoming Investor Conferences in June GlobeNewswire Inc. - 5/26/2021 7:00:00 AM
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture PR Newswire (US) - 5/25/2021 6:00:00 AM
Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening PR Newswire (US) - 5/19/2021 9:01:00 AM
Evelo up 7% after posting preclinical data on anti-inflammatory candidate Seeking Alpha - 5/13/2021 11:22:26 AM
Evelo Biosciences Presents New Preclinical Data for Extracellular Vesicle Anti-inflammatory Product Candidate EDP2939 at the ... GlobeNewswire Inc. - 5/13/2021 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/29/2021 4:36:58 PM
Evelo Biosciences EPS misses by $0.03 Seeking Alpha - 4/29/2021 7:07:24 AM
Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights GlobeNewswire Inc. - 4/29/2021 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/26/2021 4:53:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2021 4:48:54 PM
Evelo Biosciences to Report First Quarter 2021 Financial Results on Thursday, April 29, 2021 GlobeNewswire Inc. - 4/22/2021 7:00:00 AM
Evelo Biosciences releases complete dataset from early stage atopic dermatitis study Seeking Alpha - 4/20/2021 4:23:42 PM
Evelo Biosciences Presents Further Positive Data from Phase 1b Clinical Trial of EDP1815 in Atopic Dermatitis GlobeNewswire Inc. - 4/20/2021 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/15/2021 4:38:03 PM
beginneer Member Level  Thursday, 04/08/21 10:32:33 PM
Re: None
Post # of 1 
Anyone Here?

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences